Samara Biotech

Samara Biotech was an Indiana-based Purdue University startup focused on oxygen nanobubble technology intended to enhance the effectiveness of other medical treatments. Its core approach involved intravenously delivered oxygen nanobubbles that could be directed to wounds or tumors, with the goal of reversing hypoxia and improving responses to chemotherapy or radiation. Public information indicates the company explored applications in oncology and wound healing, with particular relevance to hypoxic solid tumors. The business appears to have remained at a preclinical stage, with the underlying evidence described in university communications rather than a disclosed formal clinical pipeline. Corporate registry information suggests the entity is no longer active.